Patents by Inventor Annette Friebe

Annette Friebe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9243243
    Abstract: A novel method of detecting and characterizing protein-peptide interactions is provided, which can be used for isolating peptides and proteins, respectively, as well as in drug screening and development.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: January 26, 2016
    Assignee: NEXIGEN GMBH
    Inventors: Hanjo Hennemann, Claudia Kruse, Sabine Hanke, Annette Friebe
  • Patent number: 8685652
    Abstract: Novel drug targets and antiviral agents are provided for the therapeutic intervention of lentiviral diseases, in particular AIDS.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: April 1, 2014
    Assignee: Nexigen GmbH
    Inventors: Annette Friebe, Hanjo Hennemann, Claudia Carl, Nina Schürmann, Sabine Wirths
  • Publication number: 20110065198
    Abstract: Novel drug targets and antiviral agents are provided for the therapeutic intervention of lentiviral diseases, in particular AIDS.
    Type: Application
    Filed: August 13, 2008
    Publication date: March 17, 2011
    Applicant: Nexigen GmbH
    Inventors: Annette Friebe, Hanjo Hennemann, Claudia Carl, Nina Schürmann, Sabine Wirths
  • Publication number: 20100136535
    Abstract: A novel method of detecting and characterizing protein-peptide interactions is provided, which can be used for isolating peptides and proteins, respectively, as well as in drug screening and development.
    Type: Application
    Filed: August 31, 2007
    Publication date: June 3, 2010
    Applicant: ATIFTUNG CAESAR CENTER OF ADVANCED EUROPEAN STUDIE AND Research
    Inventors: Hanjo Hennemann, Claudia Kruse, Sabine Hanke, Annette Friebe